6 Meridian’s Integra LifeSciences IART Stock Holding History

6 Meridian’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,986	Closed	-$204K	–	442
2021 Q2	$204K	Sell	2,986 -92	-3%	-$6.51K	0.02%	369
2021 Q1	$213K	Sell	3,078 -419	-12%	-$28.4K	0.02%	343
2020 Q4	$227K	Buy	+3,497	New	+$188K	0.02%	255
2018 Q3	–	Sell	-8,970	Closed	-$578K	–	463
2018 Q2	$578K	Sell	8,970 -242	-3%	-$15K	0.06%	184
2018 Q1	$510K	Sell	9,212 -2,829	-23%	-$148K	0.06%	190
2017 Q4	$576K	Buy	+12,041	New	+$589K	0.07%	181

Other funds holding IART

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

6 Meridian's IART Position: Q3 2021 in Review

6 Meridian sold out of Integra LifeSciences (IART) in Q3 2021, closing a stake of 2,986 shares — an estimated $204K sold.

6 Meridian first reported a position in IART in Q4 2017 and held it in 6 quarters. The position peaked at $578K in Q2 2018. 261 funds tracked by Wall St. Rank hold IART as of Q3 2021.

6 Meridian reported no remaining Integra LifeSciences position as of Q3 2021 after selling out during the quarter.
6 Meridian sold 2,986 Integra LifeSciences shares in Q3 2021, an estimated $204K.
6 Meridian first reported a position in Integra LifeSciences in Q4 2017 and held it in 6 quarters.
6 Meridian's Integra LifeSciences position peaked at $578K in Q2 2018.
261 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2021.

Based on 6 Meridian's 13F filing for Q3 2021, filed 3 Nov 2021.